News

Home/News

Improved Pharma at AAPS with Posters and Booth

Come see us at booth 555 and posters T1430-08-45 and T1430-08-46 Improved Pharma will be exhibiting in booth 555, conveniently located next to the 360 Center Stage. Also, Dr. Susan Bogdanowich-Knipp and Dr. Pamela Smith will be presenting posters on Tuesday afternoon from 2:30 – 3:30. The presentations will be held in Forum 8, Read more

Improved Pharma at AAPS with Posters and Booth2022-07-19T14:44:37+00:00

Improved Pharma announces new collaboration with Keystone Pharma Consulting

WEST LAFAYETTE, Ind. (PRWEB)May 11, 2022 Improved Pharma is pleased to announce a collaboration with Dr. Patricia Andres from Keystone Pharma Consulting, LLC, thus further expanding its network of pharmaceutical consultants with expertise in different areas of drug development to support its growing demand. Dr. Andres, President and founder of Keystone Pharma Consulting, LLC, Read more

Improved Pharma announces new collaboration with Keystone Pharma Consulting2022-07-27T13:36:24+00:00

Increasing the Effectiveness of Slurry Experiments to Confirm the Relative Stability of Polymorphs

Thermodynamic stability and form selection. Form selection of active pharmaceutical ingredients is regarded as an essential part of drug development. The goal of form selection is to identify the most suitable solid form for toxicological studies, drug product development, and eventually commercialization. Determining the order in which solid forms exhibit physical stability is one Read more

Increasing the Effectiveness of Slurry Experiments to Confirm the Relative Stability of Polymorphs2022-05-03T20:03:00+00:00

Improved Pharma Expands Service Offerings with Addition of VTI Corp. SGA-100 DVS for Measurement of Hygroscopicity

Improved Pharma is pleased to announce expanded capabilities with the addition of an in-house SGA-100 DVS. DVS is very useful in understanding if material is hygroscopic, and subsequently if it will lose the adsorbed water, or if material is deliquescent. In addition, DVS can aid in the identification of potential hydrates, which may be Read more

Improved Pharma Expands Service Offerings with Addition of VTI Corp. SGA-100 DVS for Measurement of Hygroscopicity2022-04-25T15:47:03+00:00

Patenting and Litigating Pharmaceutical Salts

On Thursday, April 28, at 12:30 PM ET, please join Gene Quinn, President & CEO of IPWatchdog, Inc., and our distinguished panel consisting of Dr. Stephen Byrn of Purdue University and Improved Pharma, Dr. Steven Zeman, partner and European and German patent attorney at the firm Grünecker Patent Attorneys and Attorneys at Law in Munich, Germany, and Eyal Barash, a U.S. Read more

Patenting and Litigating Pharmaceutical Salts2022-04-25T15:42:14+00:00

Improved Pharma returns to Sustainable Medicines in Africa Program

The Sustainable Medicines in Africa program, which includes a master’s degree in biotechnology innovation and regulatory science from Purdue University, returned to Arusha, Tanzania in March of 2022.  About 100 students and instructors gathered in the vast complex at St. Carolus for two weeks, participating in group projects, laboratory experiments, and lectures. The topics Read more

Improved Pharma returns to Sustainable Medicines in Africa Program2022-04-18T11:58:08+00:00

Determining the Transition Temperature of Enantiotropic Polymorphs with Slow Transformation Kinetics

Select the polymorph with attributes fit for development. It is well established that polymorphism is common in pharmaceutical active ingredients.1 Bernstein and others present statistics that, when they are appropriately screened up to three in four compounds display polymorphism.2 Because of their distinct physical and chemical property differences, polymorph control becomes an essential task Read more

Determining the Transition Temperature of Enantiotropic Polymorphs with Slow Transformation Kinetics2022-04-11T15:46:52+00:00

Detecting Small Amounts of a Polymorph or Solid Form in Drug Product

How to quantitate a solid form in your drug product. A very important aspect of pharmaceutical mixture analysis is detecting and possibly quantitating a specific solid form in a drug product, especially tablets. Chapter 22 of Solid-State Properties of Pharmaceutical Materials by Byrn, Zografi, and Chen (Wiley, 2017) outlines several approaches to mixture analysis. Read more

Detecting Small Amounts of a Polymorph or Solid Form in Drug Product2022-04-01T20:44:24+00:00

American Crystallographic Association (ACA) Summer Course in Chemical Crystallography

WEST LAFAYETTE, Ind. (PRWEB)January 19, 2022 Improved Pharma is pleased to announce its sponsorship towards the 2022 ACA Summer Course in Crystallography to be held this summer at Purdue University. The course aim is to provide appropriate training on the theory as well as practical aspects of both Single Crystal Chemical Crystallography and X-Ray Read more

American Crystallographic Association (ACA) Summer Course in Chemical Crystallography2022-01-24T18:22:52+00:00

Improved Pharma Announces Pharmaceutical R&D Efforts in 2021

WEST LAFAYETTE, Ind. (PRWEB)January 14, 2022 Developing new tools and advancing pharmaceutical development is a key part of Improved Pharma’s mission. In 2021, the results from several research and development projects were published with our team of consultants and collaborators. Most of the research focused on the development of amorphous materials and understanding their Read more

Improved Pharma Announces Pharmaceutical R&D Efforts in 20212022-01-14T20:08:42+00:00
Go to Top